Product Information
GABAPENTIN 800 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0963 per EA under NDC 72888013201. Its NADAC has been published 138 times since Nov 8, 2023.
Strength
800 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888013201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA077661On Market Since
9/22/2022
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 800 MG TABLET has been published 138 times since Nov 8, 2023, and over the history we have for it it has declined 23.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0963 per EA |
|---|---|
| All-time high | $0.1275 (Jan 10, 2024) |
| All-time low | $0.0799 (Nov 20, 2024) |
| 52-week high | $0.1035 |
| 52-week low | $0.0963 |
| Median price | $0.1028 |
| Average price | $0.1050 |
| Largest weekly change | -27.0% (Nov 20, 2024) |
| Weeks tracked | 138 |
| Tracking since | Nov 8, 2023 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 800 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.0963 per EA (NDC 72888013201), effective Jun 24, 2026.
How has the price of GABAPENTIN 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 800 MG TABLET has declined 23.0%. It has been tracked across 138 weekly CMS publications since Nov 8, 2023.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 800 MG TABLET?
Since Nov 8, 2023, the NADAC for GABAPENTIN 800 MG TABLET has ranged from a low of $0.0799 (Nov 20, 2024) to a high of $0.1275 (Jan 10, 2024), with a median of $0.1028 per EA.
Are there cheaper alternatives to GABAPENTIN 800 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as GABAPENTIN 800 MG TABLET, but none are currently priced below it.
Who manufactures GABAPENTIN 800 MG TABLET?
GABAPENTIN 800 MG TABLET (NDC 72888013201) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification